Seri Park
Overview
Explore the profile of Seri Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gadson D, Park S
Healthcare (Basel)
. 2024 Dec;
12(23).
PMID: 39685049
Background/objectives: Public health administrators are entrusted to oversee the fair and efficient implementation of public health policy. Professional standards rooted in social justice add an additional ethical standard beyond what...
2.
Tan R, Ong W, Lee K, Park S, Iqbal J, Park Y, et al.
J Natl Compr Canc Netw
. 2024 May;
22(2 D).
PMID: 38744306
Background: Although considered a favorable subtype, pure mucinous breast cancer (PMBC) can recur, and evidence for adjuvant therapy is limited. We aimed to compare outcomes of nonmetastatic PMBC with invasive...
3.
Kang D, Park S, Kim H, Lee J, Han J, Kim S, et al.
Breast Cancer
. 2024 Mar;
31(3):467-475.
PMID: 38472736
Background: In recognition of the distinct clinical challenges and research gaps in young breast cancer (YBC) patients, we established the Comprehensive Young Age Breast Cancer (CHARM) registry to collect prospective...
4.
Park S, Lee J, Na C, Kim D, Kim J, Kim D
J Air Waste Manag Assoc
. 2023 Dec;
74(2):131-144.
PMID: 38059786
Indoor air pollution remains a major concern, with formaldehyde (HCHO) a primary contributor due to its long emission period and associated health risks, including skin allergies, coughing, and bronchitis. This...
5.
Kang D, Park S, Kim H, Kim S, Lee J, Yu J, et al.
Cancer Res Treat
. 2023 Sep;
56(1):125-133.
PMID: 37669709
Purpose: We evaluated the association between changes in social support after cancer treatment and recurrence-free survival (RFS) in such patients using a prospective cohort study. Materials And Methods: Data were...
6.
Kang D, Cho J, Park S, Kim H, Kim S, Lee J, et al.
Ther Adv Med Oncol
. 2023 Aug;
15:17588359231189421.
PMID: 37547446
Background: Pretreatment endocrine symptoms in premenopausal patients might be considered as a potential marker of poor prognosis. We conducted a cohort study to evaluate the association between endocrine symptoms prior...
7.
Park Y, Im S, Park K, Wen J, Lee K, Choi Y, et al.
Genome Med
. 2023 Jul;
15(1):55.
PMID: 37475004
Background: Cyclin-dependent kinase 4/6 inhibitor (CDK4/6) therapy plus endocrine therapy (ET) is an effective treatment for patients with hormone receptor-positive/human epidermal receptor 2-negative metastatic breast cancer (HR+/HER2- MBC); however, resistance...
8.
Kim M, Kim H, Kang D, Ahn H, Shin S, Park S, et al.
J Med Internet Res
. 2023 Mar;
25:e43359.
PMID: 36951923
Background: In recent decades, real-world evidence (RWE) in oncology has rapidly gained traction for its potential to answer clinical questions that cannot be directly addressed by randomized clinical trials. Integrating...
9.
Jung J, Park S, Lee M, Chung Y, Koo B, Kim S, et al.
Ann Palliat Med
. 2022 Dec;
11(12):3636-3647.
PMID: 36510457
Background: Preoxygenation is a simple but very important procedure for preventing arterial desaturation. A higher fraction of inspired oxygen (FiO2) increases atelectasis and 80% oxygen results in significantly less atelectasis...
10.
Jo H, Park S, Kim H, Kim H, Hong J, Lee J, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230762
Background: Given that peak age of breast cancer (BC) is younger in Asians than in Western populations, relatively higher prevalence of pregnancy-associated breast cancer (PABC) has been reported. This study...